{"id":159710,"date":"2026-09-04T19:34:30","date_gmt":"2026-09-04T19:34:30","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/159710\/"},"modified":"2026-09-04T19:34:30","modified_gmt":"2026-09-04T19:34:30","slug":"first-in-the-baltics-northway-biotech-opens-e61-million-cell-therapy-and-personalized-medicine-cdmo-in-vilnius-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/159710\/","title":{"rendered":"First in the Baltics: Northway Biotech opens \u20ac61 million cell therapy and personalized medicine CDMO in Vilnius"},"content":{"rendered":"<p>                                        <img decoding=\"async\" src=\"https:\/\/news.inbox.eu\/w\/img\/7e\/83\/7e83613f5005c2c915-800x0.webp\" onerror=\"this.src=\" https:=\"\" onload=\"if(this.width &lt;= 1){this.src=\"\/><\/p>\n<p>Building on more than 22 years of CDMO experience across biologics and advanced therapies, Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 independent cGMP manufacturing lines and first customer programs already secured. The first dedicated Innovative Cell Therapy and Personalized Medicine Center [\u2026]<\/p>\n","protected":false},"excerpt":{"rendered":"Building on more than 22 years of CDMO experience across biologics and advanced therapies, Northway Biotech is significantly&hellip;\n","protected":false},"author":2,"featured_media":159711,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[93],"tags":[171,170],"class_list":["post-159710","post","type-post","status-publish","format-standard","has-post-thumbnail","category-vilnius","tag-lithuania","tag-vilnius"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117214449993969017","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/159710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=159710"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/159710\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/159711"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=159710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=159710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=159710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}